NASDAQ · SNES
Basic Materials · Chemicals - Specialty
$0.86
Down-$0.03 (-3.76%)
Updated Sep 12, 2026, 2:55 AM
SID Score
2.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
SNES closed at $0.86 after 20 trading sessions, down 28.88% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.91 | $0.9165 | $0.85 | $0.8605 | 30.06K |
| Sep 10, 2026 | $0.865 | $0.8941 | $0.865 | $0.8941 | 30.21K |
| Sep 9, 2026 | $0.89 | $0.915 | $0.84 | $0.865 | 77.77K |
| Sep 8, 2026 | $1.02 | $1.035 | $0.84 | $0.89 | 239.59K |
| Sep 4, 2026 | $1.015 | $1.0262 | $1.00 | $1.00 | 24.14K |
| Sep 3, 2026 | $1.07 | $1.0899 | $1.01 | $1.04 | 62.47K |
| Sep 2, 2026 | $1.07 | $1.08 | $1.06 | $1.06 | 7.46K |
| Sep 1, 2026 | $1.0772 | $1.08 | $1.0502 | $1.08 | 17.79K |
| Aug 31, 2026 | $1.13 | $1.13 | $1.05 | $1.06 | 24.81K |
| Aug 28, 2026 | $1.09 | $1.09 | $1.05 | $1.08 | 37.86K |
| Aug 27, 2026 | $1.14 | $1.17 | $1.05 | $1.10 | 122.5K |
| Aug 26, 2026 | $1.17 | $1.20 | $1.12 | $1.16 | 142.6K |
| Aug 25, 2026 | $1.19 | $1.2111 | $1.16 | $1.19 | 29.47K |
| Aug 24, 2026 | $1.25 | $1.25 | $1.17 | $1.19 | 38.09K |
| Aug 21, 2026 | $1.25 | $1.28 | $1.21 | $1.26 | 25.63K |
| Aug 20, 2026 | $1.28 | $1.2869 | $1.23 | $1.28 | 11.85K |
| Aug 19, 2026 | $1.29 | $1.30 | $1.2085 | $1.27 | 11.87K |
| Aug 18, 2026 | $1.27 | $1.30 | $1.19 | $1.29 | 37.58K |
| Aug 17, 2026 | $1.22 | $1.2449 | $1.18 | $1.21 | 55.22K |
| Aug 14, 2026 | $1.26 | $1.2807 | $1.18 | $1.21 | 57.51K |
The latest Smart Investors Daily articles mentioning SNES.
SNES research
Company profile and research snapshot.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Dec 13, 2024 | HC Wainwright & Co. | Buy | — |
| Dec 12, 2024 | HC Wainwright & Co. | Buy | — |
| May 14, 2024 | HC Wainwright & Co. | Buy | — |
| Dec 28, 2023 | HC Wainwright & Co. | Buy | — |
| May 24, 2023 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 9, 2026
NASDAQ: SNES Richard Hantke: Hello everyone. My name is Richard Hantke with Zacks Small Cap Research , and welcome to another episode of our CEO Chat series. Today we've got SenesTech (NASDAQ: SNES), which is involved with rodent birth control solutions, which is kind of interesting. We'll get into that. Zacks has it under coverage with our analyst M. Marin. In her most recent report a few weeks
Yahoo · Aug 31, 2026
SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that a six-month deployment of Evolve® Rat as part of a comprehensive Integrated Pest Management program reduced measured rodent activity by 43% at a municipal facility in Swampscott, Massachusetts.
Yahoo · Aug 17, 2026
SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 18, 2026.
Yahoo · Aug 10, 2026
By M. Marin NASDAQ: SNES READ THE FULL SNES RESEARCH REPORT Believe 2Q26 illustrates strong momentum on benefits of growth initiatives SenesTech, Inc. (NASDAQ: SNES), a leader in rodent birth control solutions with patented products that provide proven long-term and sustainable rodent population management, reported record 1H26 revenue, which we believe illustrates the strong momentum in the
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SNES.
